James H. MacKaness
CFO
CFO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Soleno Therapeutics Inc (SLNO) | Chief Financial Officer | $460,000 | $8,774,955 |
| 2023 | Soleno Therapeutics Inc (SLNO) | Chief Financial Officer | $400,000 | $1,211,636 |
| 2022 | Soleno Therapeutics Inc (SLNO) | Chief Financial Officer | $385,000 | $626,195 |
| 2020 | Soleno Therapeutics Inc (SLNO) | Chief Financial Officer | $198,988 | $710,468 |
Executive changes
Earnings-call appearances
-
Soleno Therapeutics Inc Q3 FY2025 Earnings Call2025-11-04
Soleno Therapeutics Inc (SLNO)
-
Soleno Therapeutics Inc Q2 FY2025 Earnings Call2025-07-10
Soleno Therapeutics Inc (SLNO)